These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 8781597)
1. Effect of calcitonin gene-related peptide on delayed cerebral vasospasm after experimental subarachnoid hemorrhage in rabbits. Imaizumi S; Shimizu H; Ahmad I; Kaminuma T; Tajima M; Yoshimoto T Surg Neurol; 1996 Sep; 46(3):263-70; discussion 270-1. PubMed ID: 8781597 [TBL] [Abstract][Full Text] [Related]
2. [Effect of calcitonin gene-related peptide and vasoactive intestinal polypeptide on delayed cerebral vasospasm studied after experimental subarachnoid hemorrhage in rabbits]. Shimizu H; Imaizumi S; Ishtiaq A; Kaminuma T; Tajima M; Yoshimoto T No Shinkei Geka; 1994 Feb; 22(2):131-9. PubMed ID: 8115007 [TBL] [Abstract][Full Text] [Related]
3. Effects of subarachnoid hemorrhage on vascular responses to calcitonin gene-related peptide and its related second messengers. Sutter B; Suzuki S; Arthur AS; Kassell NF; Lee KS J Neurosurg; 1995 Sep; 83(3):516-21. PubMed ID: 7666231 [TBL] [Abstract][Full Text] [Related]
5. Effect of intracisternal and intravenous calcitonin gene-related peptide on experimental cerebral vasospasm in rabbits. Toshima M; Kassell NF; Tanaka Y; Dougherty DA Acta Neurochir (Wien); 1992; 119(1-4):134-8. PubMed ID: 1481740 [TBL] [Abstract][Full Text] [Related]
6. Prevention of cerebral vasospasm by calcitonin gene-related peptide slow-release tablet after subarachnoid hemorrhage in monkeys. Inoue T; Shimizu H; Kaminuma T; Tajima M; Watabe K; Yoshimoto T Neurosurgery; 1996 Nov; 39(5):984-90. PubMed ID: 8905755 [TBL] [Abstract][Full Text] [Related]
7. Relaxant effect of calcitonin gene-related peptide on cerebral arterial spasm induced by experimental subarachnoid hemorrhage in dogs. Nozaki K; Uemura Y; Okamoto S; Kikuchi H; Mizuno N J Neurosurg; 1989 Oct; 71(4):558-64. PubMed ID: 2795174 [TBL] [Abstract][Full Text] [Related]
8. Vascular pathology of large cerebral arteries in experimental subarachnoid hemorrhage: Vasoconstriction, functional CGRP depletion and maintained CGRP sensitivity. Johansson SE; Abdolalizadeh B; Sheykhzade M; Edvinsson L; Sams A Eur J Pharmacol; 2019 Mar; 846():109-118. PubMed ID: 30653947 [TBL] [Abstract][Full Text] [Related]
9. The importance of substance P and calcitonin gene related peptide as vasodilator neuropeptide during acute phase of experimental posthemorrhagic vasospasm. Locatelli M J Neurosurg Sci; 2000 Dec; 44(4):186-91. PubMed ID: 11327287 [TBL] [Abstract][Full Text] [Related]
10. Development of calcitonin gene-related peptide slow-release tablet implanted in CSF space for prevention of cerebral vasospasm after experimental subarachnoid haemorrhage. Ahmad I; Imaizumi S; Shimizu H; Kaminuma T; Ochiai N; Tajima M; Yoshimoto T Acta Neurochir (Wien); 1996; 138(10):1230-40. PubMed ID: 8955444 [TBL] [Abstract][Full Text] [Related]
11. Depletion of calcitonin gene-related peptide in perivascular nerves during acute phase of posthemorrhagic vasospasm in the rabbit. Arienta C; Balbi S; Caroli M; Fumagalli G Brain Res Bull; 1991 Nov; 27(5):605-9. PubMed ID: 1756379 [TBL] [Abstract][Full Text] [Related]
12. Involvement of perivascular sensory fibers in the pathophysiology of cerebral vasospasm following subarachnoid hemorrhage. Edvinsson L; Delgado-Zygmunt T; Ekman R; Jansen I; Svendgaard NA; Uddman R J Cereb Blood Flow Metab; 1990 Sep; 10(5):602-7. PubMed ID: 1696581 [TBL] [Abstract][Full Text] [Related]
13. Cerebrovascular changes following administration of gammaglobulins against substance P or calcitonin gene related peptide in monkey with subarachnoid haemorrhage. Shiokawa Y; Holst JJ; Torben J; Rasmussen N; Schmidt P; Svendgaard NA Br J Neurosurg; 1993; 7(5):507-18. PubMed ID: 7505591 [TBL] [Abstract][Full Text] [Related]
14. Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor. Wolf EW; Banerjee A; Soble-Smith J; Dohan FC; White RP; Robertson JT J Neurosurg; 1998 Aug; 89(2):279-88. PubMed ID: 9688124 [TBL] [Abstract][Full Text] [Related]
15. [Reversal of experimental cerebral vasospasm by neuropeptides]. Nozaki K Nihon Geka Hokan; 1990 Jan; 59(1):55-67. PubMed ID: 2130769 [TBL] [Abstract][Full Text] [Related]
16. Broad-spectrum and selective serine protease inhibitors prevent expression of platelet-derived growth factor-BB and cerebral vasospasm after subarachnoid hemorrhage: vasospasm caused by cisternal injection of recombinant platelet-derived growth factor-BB. Zhang Z; Nagata I; Kikuchi H; Xue JH; Sakai N; Sakai H; Yanamoto H Stroke; 2001 Jul; 32(7):1665-72. PubMed ID: 11441217 [TBL] [Abstract][Full Text] [Related]
17. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm. Wanebo JE; Arthur AS; Louis HG; West K; Kassell NF; Lee KS; Helm GA Neurosurgery; 1998 Dec; 43(6):1409-17; discussion 1417-8. PubMed ID: 9848855 [TBL] [Abstract][Full Text] [Related]
19. Changes in vascular responses of the basilar artery to acetylcholine and endothelin-1 in an experimental rabbit vasospasm model. Kim CY; Paek SH; Seo BG; Kim JH; Han DH Acta Neurochir (Wien); 2003 Jul; 145(7):571-7. PubMed ID: 12910400 [TBL] [Abstract][Full Text] [Related]
20. Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage. Atalay B; Caner H; Cekinmez M; Ozen O; Celasun B; Altinors N Neurosurgery; 2006 Nov; 59(5):1102-7; discussion 1107-8. PubMed ID: 17143244 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]